Patent · US Active

Methods, plasmid vectors and primers for assessing HIV viral fitness

US8673551B2 · kind B2 · utility

0Cited by
6References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 7, 2006
Grant dateMar 18, 2014
Priority date
Expiry dateJan 15, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/703
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to methods and means for the evaluation of HIV replicative capacity in a given environment. In particular, the invention provides a growth competition assay that can determine relative viral fitness using a recombinant tagged HIV-1 virus system. The methods rely on plasmid vectors, amplicons, primers and probes, and the generation of replication-competent viruses therefrom. Said methods and materials may find use in multiple fields including diagnostics, drug screening, pharmacogenetics and drug development.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.